Yerba mate showed significant GLP-1 increases in animal studies, but no human studies have confirmed this effect
Among the most prominent are: Semaglutides, known as Ozempic/Wegovy (Novonordisk) Tirzepatides, known as Mounjano/Zepbound (Eli Lilly), and Liraglutides, known as Victoza/Saxenda (Novonordisk)
Evoked dopamine was moderately reduced in PTSD-like mice compared to the controls, and the KDS2010 treatment significantly restored dopamine response compared to PTSD-like mice (Supplementary Fig
For a triple-receptor agonist that targets GLP-1 , GIP, and glucagon receptors simultaneously, the neurological ripple effects are still being studied, still being understood
Visible fading of dark spots and more even tone typically appears after 24 weeks of consistent daily use